Difference between revisions of "About QIBA"
Jump to navigation
Jump to search
m |
m (→QIBA’s® ROLE) |
||
| Line 32: | Line 32: | ||
*QIBA ''accelerates'''''Bold text''' the development and adoption of hardware and software '''standards''' needed to achieve '''accurate''' and '''reproducible, quantitative (measurable) results''' from imaging methods. | *QIBA ''accelerates'''''Bold text''' the development and adoption of hardware and software '''standards''' needed to achieve '''accurate''' and '''reproducible, quantitative (measurable) results''' from imaging methods. | ||
| − | |||
| − | |||
| − | ::[[Image:clinical decision.jpg| | + | ''Clinical Decisions from Quantitative Imaging'' |
| + | |||
| + | ::[[Image:clinical decision.jpg|400px]] | ||
Revision as of 18:22, 19 November 2021
WHO IS QIBA®?
RSNA’s Quantitative Imaging Biomarkers Alliance (QIBA®) stakeholders include:
- clinical research community
- imaging equipment manufacturers
- pharmaceutical industry
- government agencies
- medical informatics companies
QIBA stakeholders ensure quantitative imaging results are:
- Consistent
- Achievable
- Reliable
- Validated
THE IMPORTANCE OF QUANTITATIVE IMAGING (QI)
QI develops, standardizes, and optimizes:
- Anatomical, functional, and molecular imaging acquisition protocols
- Data analyses
- Display methods
- Reporting structures
- Who is QIBA?
- Why is QI important?
QIBA’s® ROLE
- Efficient and validated methods for quantifying biomedical imaging results are required for optimal patient care, clinical research, and new therapy development.
- QIBA acceleratesBold text the development and adoption of hardware and software standards needed to achieve accurate and reproducible, quantitative (measurable) results from imaging methods.
Clinical Decisions from Quantitative Imaging
